These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: a prospective randomized study. Fuller KL, Wang YY, Cook MJ, Murphy MA, D'Souza WJ. Epilepsia; 2013 Jan; 54(1):45-57. PubMed ID: 22738092 [Abstract] [Full Text] [Related]
9. Efficacy and tolerability of high oral doses of levetiracetam in children with epilepsy. Obeid M, Pong AW. Epilepsy Res; 2010 Sep; 91(1):101-5. PubMed ID: 20663645 [Abstract] [Full Text] [Related]
12. An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy. Abou-Khalil B, Hemdal P, Privitera MD. Seizure; 2003 Apr; 12(3):141-9. PubMed ID: 12651078 [Abstract] [Full Text] [Related]